Media

WERVIC Firocoxib Tablets Launched: Vet-Approved Pain Relief & Anti-Inflammatory Solution for Dogs

Sep. 09, 2025

WERVIC, a leader in companion animal health solutions, today announced the official launch of WERVIC Firocoxib Tablets, a prescription non-steroidal anti-inflammatory drug (NSAID) tailored to address pain and inflammation in dogs. The new product aims to improve quality of life for canines struggling with chronic osteoarthritis discomfort or recovering from surgical procedures, such as neutering or orthopedic interventions.

非罗考西片盒子

Targeting Unmet Needs in Canine Pain Management

 

Osteoarthritis affects millions of dogs globally, particularly senior or large-breed companions, while post-surgical pain often hinders recovery and limits a dog’s mobility. WERVIC Firocoxib Tablets directly addresses these challenges by focusing on COX-2, an enzyme linked to pain and inflammation, without disrupting COX-1—a key protector of gastrointestinal and renal health.

 

“For pet parents, watching a dog struggle with pain—whether from aging joints or post-surgery soreness—is heartbreaking,” said [Your Name], [Job Title] at [Your Company Name]. “WERVIC was developed to not only relieve discomfort but also let dogs return to the activities they love: zoomies in the yard, cuddles on the couch, and playful moments with their families.”

 

Vet-Backed Benefits: Efficacy, Safety, and Convenience

 

Rigorous testing and veterinary input have shaped WERVIC Firocoxib Tablets’ core advantages, designed to balance performance with pet well-being:

 

  • Precision Pain Relief: By targeting COX-2, the product delivers fast-acting relief for osteoarthritis-related stiffness and post-surgical discomfort, supporting quicker recovery.

 

  • Enhanced Safety Profile: With up to 380x greater selectivity for COX-2 than COX-1, WERVIC minimizes the risk of gastrointestinal side effects (e.g., ulcers, vomiting) that are common with less selective NSAIDs—making it suitable for long-term chronic pain management.

 

  • Simplified Administration: Once-daily dosing, combined with compatibility with food (turning medication time into a “treat-like” experience), eliminates the stress of frequent pill-giving for both pets and owners. Dosing is also weight-based, ensuring accuracy for dogs of all sizes.

 

  • Veterinary Trust: The product has earned endorsement from practicing veterinarians for use in surgical recovery and chronic pain care. WERVIC also provides dedicated technical support to vets and pet parents, ensuring proper use.

 

  • Long Shelf Life: A 48-month shelf life allows pet parents to keep WERVIC on hand for ongoing care, without concerns about expiration.

​​​​​​​

Critical Safety Guidelines for Responsible Use

 

As a prescription medication, WERVIC Firocoxib Tablets require adherence to veterinary guidance to ensure pet safety. [Your Company Name] emphasizes the following best practices:

 

  • Veterinary Diagnosis First: Do not use WERVIC without a vet confirming the cause of pain (e.g., ruling out infections or other conditions) and assessing your dog’s eligibility (e.g., no pre-existing kidney/liver disease).

​​​​​​​

  • Strict Dosing Compliance: Never adjust doses or give “extra” medication—overdosing can lead to life-threatening issues like kidney failure or gastrointestinal bleeding.

​​​​​​​

  • Monitor for Side Effects: Watch for signs such as vomiting (especially with blood), lethargy, increased thirst/urination, or yellowing of gums/eyes. Discontinue use and contact your vet immediately if symptoms occur.​​​​​​​

 

  • Avoid Drug Interactions: Do not combine WERVIC with other NSAIDs (e.g., carprofen), steroids (e.g., prednisone), or blood thinners.

​​​​​​​

  • Special Cases: WERVIC is not recommended for dogs under 6 months old, pregnant/lactating dogs, or those with a history of ulcers or organ disease.

​​​​​​​

Availability and Next Steps

 

WERVIC Firocoxib Tablets are now available exclusively through licensed veterinary clinics nationwide. Pet parents interested in the product should consult their vet to determine if it is right for their dog. For additional information—including technical resources for veterinarians—visit https://www.victorypharmgroup.com/.

 

“Our mission is to create solutions that prioritize both efficacy and pet safety,”“With WERVIC, we’re giving pet parents a reliable way to help their dogs live happier, more comfortable lives—one dose at a time.”

Terbinafine Hydrochloride Spray
Terbinafine Hydrochloride Spray
Terbinafine hydrochloride is a broad-spectrum antifungal drug of the allylamine class.
Terbinafine Hydrochloride Tablets
Terbinafine Hydrochloride Tablets
Terbinafine hydrochloride is an allylamine-class drug with broad-spectrum antifungal activity.
Hairball Remedy Paste for Cats
Hairball Remedy Paste for Cats
Hairball Remedy Paste for Cats
Healthy Heart Chewable Tablets
Healthy Heart Chewable Tablets
Protect your pet's heart health
Healthy Liver Chewable Tablets
Healthy Liver Chewable Tablets
Acety-L-Cysteine, MilkThistle Extract, VitaminE.Zinc, Taurine Vitamin B6,Vitamin B1,Vitamin B2,Vitamin B12,Niacinamide
Viclaner chewable tablets for dog
Viclaner chewable tablets for dog
Character : Light brown to dark brown round piece Main ingredient: Fluralaner 112.5mg 250mg 500mg 1000mg 1400mg Indication: It is used to treat flea and tick infection on the dog's body surface, and can also assist in the treatment of allergic dermatitis caused by fleas.
Heartworm Remedy Plus Dog Dewormer
Heartworm Remedy Plus Dog Dewormer
Heartworm Remedy Plus Dog Dewormer
GET IN TOUCH
Needs Help? Let’s Get in Touch
    • aaa--bbbb
    • Afghanistan
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antarctica
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • BBhutan
    • Bolivia
    • Bosnia and Herzegovina
    • Botswana
    • Bouvet Island
    • Brazil
    • British Indian Ocean Territory
    • Brunei Darussalam
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo
    • Cook Islands
    • Costa Rica
    • Cote D'Ivoire
    • Croatia
    • Cuba
    • Cyprus
    • Czech Republic
    • Denmark
    • Djibouti
    • Dominica
    • East Timor
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands (Malvinas)
    • Faroe Islands
    • Fiji
    • Finland
    • France, Metropolitan
    • French Guiana
    • French Polynesia
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Honduras
    • Hong Kong, China
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran (Islamic Republic of)
    • Iraq
    • Ireland
    • Israel
    • Italy
    • Jamaica
    • Japan
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • North Korea
    • South Korea
    • Kuwait
    • Kyrgyzstan
    • Lao People's Democratic Republic
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libyan Arab Jamahiriya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macau
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Micronesia
    • Moldova
    • Monaco
    • Mongolia
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • Northern Mariana Islands
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Reunion
    • Romania
    • Russian Federation
    • Rwanda
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Saudi Arabia
    • Senegal
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovak Republic
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • Spain
    • Sri Lanka
    • St. Helena
    • Sudan
    • Suriname
    • Swaziland
    • Sweden
    • Switzerland
    • Syrian Arab Republic
    • Taiwan, China
    • Tajikistan
    • Tanzania
    • Thailand
    • Togo
    • Tokelau
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Turks and Caicos Islands
    • Tuvalu
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican City State (Holy See)
    • Venezuela
    • Viet Nam
    • Virgin Islands (U.S.)
    • Wallis and Futuna Islands
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
    • Montenegro
    • Serbia
    • Palestine
    • South Sudan
    • Jersey